Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Bhandari

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Young Pharmacists : JYP|September 8, 2011
Sepbox technique in natural productsM Bhandari, Anil Bhandari, A Bhandari
Ancient Science of Life|January 4, 2013
Antioxidant potential and total phenolic content of methanolic bark extract of Madhuca indica (koenig) GmelinAnu Chaudhary, Anil Bhandari, A Pandurangan
Pharmaceutical Methods|June 20, 2013
Recent updates on codeineMonika Bhandari, Anil Bhandari, Aakanksha Bhandari
Journal of Cardiovascular Pharmacology and Therapeutics|May 23, 2009
The mechanism by which ischemic postconditioning reduces reperfusion arrhythmias in rats remains elusiveJoan Dow, Anil Bhandari, Robert A Kloner
Pharmaceutical Biology|October 11, 2013
Pharmacognostic standardization with various plant parts of Desmostachya bipinnataAnupama Singh, Vikas Anand Saharan, Anil Bhandari
Journal of Cardiovascular Pharmacology and Therapeutics|May 23, 2008
Ischemic postconditioning's benefit on reperfusion ventricular arrhythmias is maintained in the senescent heartJoan Dow, Anil Bhandari, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|May 17, 2006
Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusionRobert A Kloner, Joan Dow, Anil Bhandari
Cardiovascular Therapeutics|July 15, 2010
The antianginal agent ranolazine is a potent antiarrhythmic agent that reduces ventricular arrhythmias: through a mechanism favoring inhibition of late sodium channelRobert A Kloner, Joan S Dow, Anil Bhandari
Journal of Cardiovascular Pharmacology and Therapeutics|January 4, 2011
First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion modelRobert A Kloner, Joan S Dow, Anil Bhandari
Pharmaceutical Biology|January 15, 2014
Antihyperglycemic and antihyperlipidemic effects of Salvadora persica in streptozotocin-induced diabetic ratsMangal Sain Hooda, Rishi Pal, Anil Bhandari, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Young Pharmacists : JYP|September 8, 2011
Sepbox technique in natural productsM Bhandari, Anil Bhandari, A Bhandari
Ancient Science of Life|January 4, 2013
Antioxidant potential and total phenolic content of methanolic bark extract of Madhuca indica (koenig) GmelinAnu Chaudhary, Anil Bhandari, A Pandurangan
Pharmaceutical Methods|June 20, 2013
Recent updates on codeineMonika Bhandari, Anil Bhandari, Aakanksha Bhandari
Journal of Cardiovascular Pharmacology and Therapeutics|May 23, 2009
The mechanism by which ischemic postconditioning reduces reperfusion arrhythmias in rats remains elusiveJoan Dow, Anil Bhandari, Robert A Kloner
Pharmaceutical Biology|October 11, 2013
Pharmacognostic standardization with various plant parts of Desmostachya bipinnataAnupama Singh, Vikas Anand Saharan, Anil Bhandari
Journal of Cardiovascular Pharmacology and Therapeutics|May 23, 2008
Ischemic postconditioning's benefit on reperfusion ventricular arrhythmias is maintained in the senescent heartJoan Dow, Anil Bhandari, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|May 17, 2006
Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusionRobert A Kloner, Joan Dow, Anil Bhandari
Cardiovascular Therapeutics|July 15, 2010
The antianginal agent ranolazine is a potent antiarrhythmic agent that reduces ventricular arrhythmias: through a mechanism favoring inhibition of late sodium channelRobert A Kloner, Joan S Dow, Anil Bhandari
Journal of Cardiovascular Pharmacology and Therapeutics|January 4, 2011
First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion modelRobert A Kloner, Joan S Dow, Anil Bhandari
Pharmaceutical Biology|January 15, 2014
Antihyperglycemic and antihyperlipidemic effects of Salvadora persica in streptozotocin-induced diabetic ratsMangal Sain Hooda, Rishi Pal, Anil Bhandari, et al.
Pageof 3